Note: Ingredients listed on restricted chemical lists
EC/CAS
9036-19-5
Name of the chemical
Octylphenolethoxylates (OPEO)
Concentration
N/A
EC/CAS
110-91-8
Name of the chemical
Morpholine
Concentration
N/A
EC/CAS
203-815-1
Name of the chemical
Morpholine and its salts
Concentration
N/A
General Information
Revision date
2019-06-01
Product name
NycoCard HbA1c
supplier name
Abbott Diagnostics Technologies AS
Manufacturer Name
Abbott Diagnostics Technologies AS
Icons in SDS
Company Information
company name
Abbott Diagnostics Technologies AS
e-mail address of the competent person responsible for the Safety Data Sheet
aleretech.no@alere.com -
Section 2
CLP CLASSIFICATION
Not classified
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling according to Regulation (EC) No. 1272/2008 [CLP]Extra labelling to displayExtra classification(s) to display
Supplemental label elements
EUH210 - Safety data sheet available on request.
Additional information
In vitro diagnostic medical devices, regulation 1272/2008/EC, article 1, paragraph 5d.
Other hazards which do not result in classification
None under normal conditions. This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII
